THE EFFICIENCY OF STEREOTAXIC RADIOTHERAPY IN PATIENTS WITH LIVER METASTASESстатьяИсследовательская статья
Статья опубликована в журнале из списка RSCI Web of Science
Статья опубликована в журнале из перечня ВАК
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 8 апреля 2022 г.
Аннотация:Aim. To determine the effectiveness of stereotaxic radiotherapy in patients with liver metastases. Material and Methods. Stereotaxic radiotherapy of liver metastatic tumors was carried out in three fractions for 5-8 days with single focal dose of 10, 12, 15, or 20 Gy. The procedure was performed in 66 patients including 40 (60.5%) women and 26 (39.5%) men. The average age was 60 years (37-82). In 24 (36.5%) cases primary tumor was presented by colorectal cancer, in 12 (18%) - breast cancer, in 7 (10.5%) - ovarian cancer and in 23 (35%) - other malignant tumors. Results. Median follow-up was 14.5 months (range 1.8-53.5). 3 patients did not present data of control examination. Among other 63 patients full effect was established in 16 (25.5%) cases, in 30 (47.5%) patients - partial regression of metastases, in 11 (17.5%) - stabilization, in 6 (9.5%) - progression of tumoral process. Thus, local control rate was 90.5%. Degree III of radiation damage was reported in 2 cases (3%), II - in 7 cases (11%). Conclusion. Stereotaxic radiotherapy seems highly effective and safe method of the treatment of patients with liver metastases and can be recommended for use in patients with limited liver metastases who have been denied in surgery.